Financial Reports Latest Updates Industry Maps Economic Calendar

PROTHENA CORP PUBLIC LTD CO (PRTA) Annual Reports

Q: Where can I read PROTHENA CORP PUBLIC LTD CO (PRTA) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

PROTHENA CORP PUBLIC LTD CO is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1559053 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$1.0M	$4.4M	-77.1%
Operating income	$-21.1M	$-84.6M	+75.1%
Net income	$-18.6M	$-125.8M	+85.2%
EPS (diluted)	$-0.36	$-2.34	+84.6%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 1.01 mn Net income -18.6 mn

Show table：Income statement

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	—	—	2.66	0.17	0.17	0.17	0.17	32.2	15.1	1.49	2.01	0.59	0.28	0.43	0.31	0.27	0.33	0.29	0.17	0.26	26.8	0.22	0.23	0.23	0.28	0.26	0.19	0.19	0.17	0.21	0.26	0.14	0.2	0.16	0.36	0.16	60.1	139	1.17	1.15	1.31	1.52	49.9	2.17	4.02	84.9	0.32	0.05	132	0.97	2.12	2.83	4.42	2.42	0.02	51.1	1.01
Operating income	-29.2	-10.8	-9.71	-8.67	-12.2	-8.97	-11.2	-9.57	-10.7	18.0	1.57	-13.1	-13.1	-15.0	-18.0	-22.7	-24.2	-27.4	-40.2	-42.7	-49.3	-36.3	-18.1	-53.5	-47.3	-48.7	-63.1	-24.3	-22.8	-22.9	-18.5	-21.0	-23.3	-24.9	-26.7	-30.9	-30.3	-32.1	27.9	109	-33.1	-37.9	-43.2	-50.3	-0.07	-56.3	-66.5	10.3	-78.5	-81.5	58.4	-66.5	-64.9	-65.6	-84.6	-40.2	-24.2	30.0	-21.1
Net income	-29.7	-10.8	-9.71	-8.67	-12.2	-8.95	-11.3	-9.69	-11.1	17.9	1.29	-13.2	-13.1	-15.2	-18.3	-23.0	-24.2	-27.5	-40.4	-43.2	-48.9	-35.4	-17.7	-52.4	-47.8	-48.7	-59.9	-24.6	-22.5	-20.9	-15.8	-19.4	-21.6	-23.6	-26.3	-30.6	-30.7	-36.7	27.6	109	-33.2	-36.3	-41.2	-45.8	6.35	-46.9	-54.6	21.9	-67.5	-72.2	66.9	-59.0	-58.0	-60.2	-126	-36.5	-21.6	32.7	-18.6

Balance sheet

Quarterly · In mn (USD)

Total assets 303 mn Total liabilities 15.7 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	—	126	121	114	103	178	200	307	309	299	284	406	394	377	482	451	416	391	514	512	469	426	537	494	457	431	415	419	409	378	360	341	320	299	352	409	608	585	556	521	525	719	700	677	691	639	566	586	535	485	436	385	340	315	339	292
Total assets	—	—	—	—	129	124	118	108	182	204	312	314	304	290	411	399	385	491	503	480	460	582	579	538	496	607	563	525	499	460	462	451	419	399	379	356	333	380	436	633	609	581	550	554	758	742	721	747	696	623	646	595	547	495	399	353	327	350	303
Current liabilities	—	—	—	—	1.74	5.09	9.08	7.72	7.41	8.96	11.3	9.97	12.0	9.54	13.5	18.6	22.2	23.2	33.5	36.9	41.1	33.7	39.6	39.3	37.4	35.6	46.1	23.6	14.9	14.9	28.0	31.8	17.7	17.1	18.5	21.7	25.9	23.5	52.9	29.2	33.5	36.5	40.1	50.6	50.1	48.9	71.6	53.4	56.9	43.3	46.7	46.4	48.5	48.5	67.8	51.4	40.8	32.5	11.7
Total liabilities	—	—	—	—	2.80	6.48	10.7	9.15	9.14	10.8	13.3	12.0	14.2	12.2	15.9	21.0	24.6	25.5	71.7	78.5	94.6	85.7	92.0	91.4	89.1	197	207	185	176	147	159	162	146	144	144	146	149	145	148	142	143	143	142	150	136	134	139	130	135	121	63.6	60.9	60.2	57.7	74.7	57.6	46.3	37.3	15.7
Equity	-6.44	—	—	—	126	118	107	98.8	173	193	298	302	290	277	395	378	361	466	431	401	365	496	487	446	407	410	356	340	323	312	303	289	273	255	234	210	184	235	288	490	466	439	407	405	622	607	582	617	561	502	582	534	487	438	324	295	280	313	287

Cash flow

Quarterly · In mn (USD)

Operating -25.1 mn Investing -0.65 mn Financing -15.6 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-19.7	-8.62	-10.4	-7.45	-15.6	-5.10	-6.85	-10.3	-9.84	17.9	6.21	-12.3	-12.5	-14.7	-11.1	-16.9	-19.7	-25.1	-27.5	-30.6	-34.0	-37.8	-36.1	-17.7	-39.5	-31.6	58.1	-33.6	-21.3	-17.4	-12.1	-8.94	-14.5	-23.2	-18.7	-19.4	-19.1	-33.7	36.6	112	-22.5	-37.4	-35.3	-31.2	-4.98	-47.5	-44.9	9.52	-51.0	-73.0	16.0	-45.2	-47.8	-53.4	-46.3	-40.6	-23.3	28.9	-25.1
Investing	-0.59	-0.14	-0.03	-0.1	-1.03	-0.11	-0.2	-0.23	0	-0.03	-0.33	-0.11	-0.04	-0.03	-0.04	-0.33	-0.98	-0.24	-4.76	-8.55	-3.09	-2.40	-0.21	-0.54	-0.38	-0.18	-0.1	-0.15	-1.30	-0.12	-0.07	-0.25	-0.11	-0.02	-0.05	-0.08	-0.05	-0.05	0	-0.21	-0.32	-0.02	-0.16	-0.13	-0.15	-0.05	-0.77	-0.44	-1.51	-0.1	-0.14	-0.01	-0.04	-0.04	-0.09	-0.01	0	0	-0.65
Financing	20.3	8.76	10.4	7.55	142	-0.08	0	-0.12	84.7	0.51	103	14.7	-0.01	1.03	134	2.66	3.45	129	0.99	4.77	19.5	160	1.47	2.61	1.46	43.2	-0.86	-0.97	-1.30	0.01	0.21	0	0.01	0.15	0	0.06	0	81.3	20.2	87.0	1.77	1.34	1.23	18.1	221	23.3	18.6	2.71	0.48	0.84	0.44	0.33	-0.06	-0.05	-0.07	-0.02	0	-6.95	-15.6
Cash at period end	0	—	—	0	125	120	113	102	177	195	304	306	294	280	402	388	371	474	443	409	387	507	472	456	418	429	486	452	428	410	398	390	376	353	334	315	295	343	400	600	579	543	509	496	710	686	659	671	619	547	564	519	471	418	371	331	308	329	288

Profitability

Quarterly · %

Operating margin -2089.2% Net margin -1839.9%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating margin	—	—	—	—	-459.7%	-5243.9%	-6701.8%	-5594.1%	-6408.4%	55.9%	10.4%	-883.7%	-651.0%	-2534.4%	-6487.4%	-5282.3%	-7886.6%	-10343.4%	-12060.1%	-14925.9%	-28817.0%	-14004.3%	-67.6%	-24444.8%	-20662.5%	-21457.3%	-22605.4%	-9538.4%	-11729.4%	-12340.9%	-11076.0%	-10230.2%	-9091.4%	-17622.7%	-13708.7%	-19647.1%	-8418.9%	-20068.1%	46.5%	78.5%	-2823.6%	-3290.9%	-3293.4%	-3317.9%	-0.1%	-2596.8%	-1654.7%	12.2%	-24846.5%	-163056.0%	44.2%	-6857.0%	-3056.8%	-2319.0%	-1914.4%	-1666.3%	-115252.4%	58.8%	-2089.2%
Net margin	—	—	—	—	-459.8%	-5234.5%	-6767.7%	-5666.1%	-6619.2%	55.4%	8.5%	-887.1%	-651.3%	-2563.6%	-6574.5%	-5355.7%	-7868.7%	-10385.3%	-12145.6%	-15118.5%	-28598.3%	-13661.8%	-66.0%	-23924.2%	-20855.0%	-21472.7%	-21463.1%	-9631.0%	-11577.8%	-11217.7%	-9467.1%	-9486.8%	-8419.5%	-16715.6%	-13478.0%	-19475.8%	-8532.2%	-22959.4%	46.0%	78.5%	-2831.0%	-3147.4%	-3143.6%	-3016.7%	12.7%	-2160.6%	-1358.4%	25.8%	-21353.2%	-144478.0%	50.7%	-6082.6%	-2729.9%	-2128.5%	-2845.4%	-1513.1%	-102804.8%	64.0%	-1839.9%

Returns & leverage

Quarterly · %

ROE -14.4% ROA -12.5% Debt ratio 5.2%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	-69.0%	-33.6%	-38.4%	-42.7%	-27.4%	-9.1%	-0.8%	-2.5%	-3.1%	-17.1%	-17.2%	-20.5%	-24.8%	-25.0%	-27.9%	-34.8%	-44.1%	-34.9%	-31.6%	-36.4%	-39.7%	-36.8%	-49.5%	-46.0%	-42.6%	-35.4%	-25.4%	-25.0%	-26.1%	-28.3%	-33.8%	-40.9%	-48.6%	-50.8%	-26.9%	19.8%	20.6%	20.0%	-0.4%	-35.0%	-21.5%	-24.4%	-28.5%	-14.3%	-24.9%	-31.1%	-8.8%	-22.9%	-23.3%	-23.5%	-66.8%	-67.6%	-63.6%	-40.3%	-14.4%
ROA	—	—	—	—	-32.0%	-31.8%	-34.9%	-39.1%	-26.3%	-8.7%	-0.8%	-2.4%	-2.9%	-16.3%	-16.5%	-19.5%	-23.4%	-23.8%	-25.2%	-30.8%	-37.9%	-31.3%	-26.9%	-30.4%	-32.0%	-28.0%	-36.5%	-34.1%	-31.3%	-24.0%	-16.3%	-16.1%	-16.9%	-18.7%	-21.6%	-25.3%	-29.6%	-31.9%	-17.3%	14.1%	14.2%	14.0%	-0.3%	-26.4%	-17.1%	-19.3%	-22.2%	-11.3%	-20.2%	-25.3%	-7.5%	-19.6%	-19.7%	-19.7%	-58.0%	-59.2%	-55.9%	-35.8%	-12.5%
Debt ratio	—	—	—	—	2.2%	5.2%	9.1%	8.5%	5.0%	5.3%	4.3%	3.8%	4.7%	4.2%	3.9%	5.3%	6.4%	5.2%	14.3%	16.4%	20.6%	14.7%	15.9%	17.0%	18.0%	32.5%	36.8%	35.3%	35.2%	32.1%	34.5%	35.9%	34.9%	36.1%	38.1%	41.1%	44.7%	38.2%	34.0%	22.5%	23.5%	24.5%	25.9%	27.0%	17.9%	18.1%	19.3%	17.4%	19.4%	19.4%	9.9%	10.2%	11.0%	11.6%	18.7%	16.4%	14.2%	10.7%	5.2%

EPS

Quarterly · US$

EPS US$-0.36

Show table：EPS

Item	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	-0.51	-0.64	-0.55	—	0.78	0.06	-0.48	-0.48	-0.55	-0.59	-0.73	-0.76	-0.81	-1.18	-1.26	-1.41	-0.99	-0.46	-1.37	-1.24	-1.26	-1.50	-0.62	-0.56	-0.52	-0.40	-0.49	-0.54	-0.59	-0.66	-0.77	-0.77	-0.91	0.58	2.13	-0.74	-0.78	-0.88	-0.97	0.16	-0.89	-1.03	0.38	-1.26	-1.34	1.22	-1.10	-1.07	-1.12	-2.34	-0.68	-0.40	0.60	-0.36

Revenue & profit

Year-to-date · In mn (USD)

Revenue 52.1 mn Net income 14.1 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 303 mn Total liabilities 15.7 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 3.83 mn Investing -0.65 mn Financing -22.5 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Operating margin 17.1% Net margin 27.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -14.4% ROA -12.5% Debt ratio 5.2%

EPS

Year-to-date · US$

EPS US$0.24

Revenue & profit

Annual · In mn (USD)

Revenue 9.68 mn Net income -244 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	—	0.68	50.9	1.61	1.06	27.5	0.96	0.81	0.85	201	53.9	91.4	135	9.68
Operating income	-41.4	-40.4	-6.65	-79.9	-160	-155	-159	-85.7	-113	72.0	-132	-191	-155	-215
Net income	-41.4	-41.0	-7.15	-80.6	-160	-153	-156	-77.7	-111	67.0	-117	-147	-122	-244

Balance sheet

Annual · In mn (USD)

Total assets 327 mn Total liabilities 46.3 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	126	178	299	377	391	426	431	378	299	585	719	639	485	315
Total assets	129	182	304	385	460	496	499	419	333	609	758	696	547	327
Current liabilities	1.74	7.41	12.0	22.2	41.1	37.4	14.9	17.7	25.9	33.5	50.1	56.9	48.5	40.8
Total liabilities	2.80	9.14	14.2	24.6	94.6	89.1	176	146	149	143	136	135	60.2	46.3
Equity	126	173	290	361	365	407	323	273	184	466	622	561	487	280

Cash flow

Annual · In mn (USD)

Operating -164 mn Investing -0.14 mn Financing -0.14 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-42.1	-32.1	-0.68	-62.5	-117	-131	-28.3	-53.0	-80.4	92.6	-109	-134	-150	-164
Investing	-1.30	-0.53	-0.5	-1.38	-16.6	-3.52	-1.73	-0.55	-0.2	-0.57	-0.46	-2.77	-0.3	-0.14
Financing	168	84.5	118	141	154	165	40.0	0.23	0.22	190	241	45.1	1.55	-0.14
Cash at period end	125	177	294	371	387	418	428	376	295	579	710	619	471	308

Profitability

Annual · %

Operating margin -2216.4% Net margin -2520.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating margin	—	-5980.3%	-13.1%	-4974.3%	-15121.8%	-564.2%	-16634.0%	-10527.9%	-13216.2%	35.9%	-244.1%	-209.1%	-114.4%	-2216.4%
Net margin	—	-6064.5%	-14.1%	-5016.3%	-15176.1%	-556.8%	-16297.9%	-9542.6%	-13029.8%	33.4%	-216.9%	-160.9%	-90.5%	-2520.6%

Returns & leverage

Annual · %

ROE -63.6% ROA -55.9% Debt ratio 14.2%

Show table：Returns & leverage

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-32.7%	-27.4%	-3.1%	-24.8%	-44.1%	-39.7%	-42.6%	-26.1%	-48.6%	20.6%	-21.5%	-24.9%	-23.3%	-63.6%
ROA	-32.0%	-26.3%	-2.9%	-23.4%	-37.9%	-32.0%	-31.3%	-16.9%	-29.6%	14.2%	-17.1%	-20.2%	-19.7%	-55.9%
Debt ratio	2.2%	5.0%	4.7%	6.4%	20.6%	18.0%	35.2%	34.9%	44.7%	23.5%	17.9%	19.4%	11.0%	14.2%

EPS

Annual · US$

EPS US$-4.54

Show table：EPS

Item	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	-0.12	-2.63	-4.66	-4.06	-3.94	-1.95	-2.79	1.06	-2.47	-2.80	-2.29	-4.54

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read PROTHENA CORP PUBLIC LTD CO (PRTA) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.